Drug Approval | June 11, 2026
AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
